Safeguard Scientifics, Inc.
SFES
$0.979
$0.0090.93%
OTC PK
| 12/31/2023 | 09/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 52.25% | 10.71% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 52.25% | 10.71% | |||
| Operating Income | -52.25% | -10.71% | |||
| Income Before Tax | -573.61% | 132.56% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -573.61% | 132.56% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -573.61% | 132.56% | |||
| EBIT | -52.25% | -10.71% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -570.98% | 132.26% | |||
| Normalized Basic EPS | -298.64% | 71.39% | |||
| EPS Diluted | -586.54% | 131.78% | |||
| Normalized Diluted EPS | -298.64% | 71.39% | |||
| Average Basic Shares Outstanding | 0.60% | 0.88% | |||
| Average Diluted Shares Outstanding | 0.60% | 0.88% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||